Asymptomatic Carotid Stenosis and Mobility Function With Exercise Intervention

NCT ID: NCT05436600

Last Updated: 2025-03-03

Basic Information

• Recruitment Status: RECRUITING
• Clinical Phase: NA
• Total Enrollment: 50 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2022-10-01
• Study Completion Date: 2028-02-29

Brief Summary

Moderate (50-69%) asymptomatic carotid artery stenosis (ACAS) is an important and under-appreciated contributor to balance and mobility dysfunction. This is significant because declines in balance and mobility are a significant predictor of falls, disability, loss of independence, and death in older adults. Further, falls and fall-related injuries in older adults cost approximately 50 billion dollars annually in the United States, and are the leading cause of adverse events reported by the Veterans Health Administration. This proposal seeks to: 1) investigate the impact of a supervised aerobic and challenging balance exercise program on balance and mobility function in patients with moderate ACAS; and 2) elucidate whether these changes are related to changes in cerebral perfusion. With 830,000 Veterans estimated to have moderate ACAS and at risk for balance and mobility dysfunction and increased falls, the findings from this study could have significant impacts on the clinical management, quality of life, and functional independence of Veterans with moderate ACAS.

Detailed Description

The investigators will conduct a prospective randomized controlled trial designed to evaluate the effects of a supervised aerobic and challenging balance exercise (AeroBal) program on balance and mobility function (primary outcome), and fall risk and physical function (secondary outcomes) in patients with moderate ACAS. The investigators hypothesize that aerobic and challenging balance exercises will lead to greater improvement in balance and mobility function, de-creased fall risk, and improved perceived physical function in patients with moderate ACAS compared to standard-of-care vascular risk-factor reduction alone. Patients will undergo 1:1 blocked randomization on sex into either the exercise training group plus standard-of-care or the control group undergoing standard-of-care vascular risk-factor modification alone. To account for attrition, the investigators aim to enroll a total of 50 patients and anticipate completing the study with 34 patients. Baseline demographic data, medical history, balance and mobility function, physical function, cerebral perfusion (PW-MRI and fNIRS) and vasoreactivity (TCD) will be collected on all patients. The exercise training group will perform 12 weeks of supervised aerobic and balance exercises. In order to maintain consistency in contact between the clinical research team and the control subjects versus the intervention group, control participants will be contacted via telephone on a weekly basis to discuss the importance of vascular risk factor management and adherence to prescribed medical management. To assess the change in outcome measures, the investigators will repeat measurements in both groups at 6- and 12-weeks. PW-MRI will only be performed at the 12-week visit to minimize patient risk and contain costs. The primary outcome measure (change in Mini BESTest score) and secondary measures (fall rate and physical function) for Aim 1, and the primary outcome measure (TTP on PW-MRI) and secondary outcome measures (BHI on TCD and change in oxy-hemoglobin concentration on fNIRS) for Aim 2 will be analyzed.

Conditions

Asymptomatic Carotid Stenosis (50-69%); Mobility Impairment

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Control

The control group will undergo standard-of-care vascular risk factor modification. Control participants will be contacted via telephone on a weekly basis to discuss the importance of vascular risk factor management and adherence to prescribed medical management.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Exercise Intervention

The exercise intervention group will undergo 12 weeks of AeroBal exercise training (approximately 3 times/week). Each exercise session will consist of a 5-minute warm-up walk, approximately 30 minutes of aerobic exercise at a goal of 60-75% HRmax, 15 minutes of balance exercises, and a 5-minute cool-down walk.

Group Type: EXPERIMENTAL

Exercise Intervention

Intervention Type: OTHER

The exercise intervention group will undergo 12 weeks of AeroBal exercise training (approximately 3 times/week). Each exercise session will consist of a 5-minute warm-up walk, approximately 30 minutes of aerobic exercise at a goal of 60-75% HRmax, 15 minutes of balance exercises, and a 5-minute cool-down walk.

Interventions

Exercise Intervention

The exercise intervention group will undergo 12 weeks of AeroBal exercise training (approximately 3 times/week). Each exercise session will consist of a 5-minute warm-up walk, approximately 30 minutes of aerobic exercise at a goal of 60-75% HRmax, 15 minutes of balance exercises, and a 5-minute cool-down walk.

Intervention Type: OTHER

Other Intervention Names

AeroBal exercise intervention

Eligibility Criteria

Inclusion Criteria

• Eligible patients will be at least 18 years of age and will have asymptomatic 50-69% carotid stenosis
• Asymptomatic status will be confirmed as in NIH trials on asymptomatic carotid stenosis, by medical history, physical examination, and the National Institutes of Health Stroke Scale (NIHSS)
• Stenosis severity will be determined by duplex sonography, MR angiography, or CT angiography

Exclusion Criteria

• previous stroke or transient ischemic attack
• occlusion or severe stenosis of the non-index carotid artery
• planned carotid revascularization
• persons advised by their doctor not to exercise
• a medical condition that precludes the ability to ambulate
• exercise or reduces the likelihood of follow-up
• evidence of a medical condition that would lead to an increased risk of accident, injury, or illness as a result of the proposed testing or intervention
• orthostatic hypotension
• severe medical illness that interferes with the evaluation of outcomes
• uncorrected visual impairment or eye surgery in the past 6 months
• patients that are unable to undergo PW-MRI due to gadolinium contrast allergy or renal insufficiency will also be excluded
• given the possibility that comorbid cognitive impairment may influence balance and mobility function, subjects with any documented medical history of dementia or cognitive impairment or those unable to follow commands will be excluded from the study
• In addition, subjects with other neurological conditions such as Parkinson's, peripheral neuropathy or myopathy, sedative medications, and major depression (Center for Epidemiological Studies Depression Survey Score >16) will be excluded
• in order to avoid ceiling effects of the Mini BESTest, potential subjects will be prescreened for balance dysfunction using a 10-second Single Leg Stance Test

• those that are able to complete the test without losing balance on either side will be excluded from the study
• the investigators will exclude subjects that participate in structured aerobic exercise routinely greater than three times per week within a month of starting the study

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 89 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

VA Office of Research and Development

FED

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Sarasijhaa K Desikan, MD

Role: PRINCIPAL_INVESTIGATOR

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Locations

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Baltimore, Maryland, United States

Site Status: RECRUITING

Countries

United States

Central Contacts

Sarasijhaa K Desikan, MD

Role: CONTACT

sdesikan@som.umaryland.edu

(410) 605-7000

Kimberlly A Nordstrom

Role: CONTACT

knordstrom@som.umaryland.edu

(410) 706-3941

Facility Contacts

Frederick M Ivey, PhD

Role: primary

Frederick.Ivey@va.gov

410-605-7000 ext. 56510

Natalie V Dugger, BS

Role: backup

Natalie.Dugger@va.gov

(410) 605-7000 ext. 56407

Other Identifiers

1IK2RX003798-01A2

Identifier Type: NIH

Identifier Source: secondary_id

View Link

E3798-W

Identifier Type: -

Identifier Source: org_study_id